AC Immune S.A.
Get $10 bonus on your first $100 deposit for ACIU
Get $10 bonus on your first $100 deposit for ACIU
AC Immune S.A. (ACIU) Stock Competitors & Peer Comparison
See (ACIU) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ACIU | $3.07 | -2.23% | 312.4M | -3.49 | -$0.88 | N/A |
| VRTX | $435.65 | -1.37% | 110.7B | 28.46 | $15.31 | N/A |
| REGN | $746.00 | -1.05% | 77.5B | 17.98 | $41.49 | +0.48% |
| VRNA | $106.91 | +0.11% | 72.7B | -102.80 | -$1.04 | N/A |
| ARGX | $828.35 | -1.49% | 51.3B | 42.26 | $19.60 | N/A |
| SGEN | $228.74 | -0.07% | 43.2B | -57.19 | -$4.00 | N/A |
| ALNY | $320.13 | -3.98% | 42.5B | 136.23 | $2.35 | N/A |
| INSM | $142.79 | -2.69% | 30.8B | -22.21 | -$6.43 | N/A |
| RVMD | $149.27 | -2.14% | 29.5B | -25.05 | -$5.95 | N/A |
| BNTX | $102.12 | +2.66% | 25.7B | -18.64 | -$5.48 | N/A |
Stock Comparison
ACIU vs VRTX Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, VRTX has a market cap of 110.7B. Regarding current trading prices, ACIU is priced at $3.07, while VRTX trades at $435.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas VRTX's P/E ratio is 28.46. In terms of profitability, ACIU's ROE is -1.02%, compared to VRTX's ROE of +0.23%. Regarding short-term risk, ACIU is more volatile compared to VRTX. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check VRTX's competition here
ACIU vs REGN Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, REGN has a market cap of 77.5B. Regarding current trading prices, ACIU is priced at $3.07, while REGN trades at $746.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas REGN's P/E ratio is 17.98. In terms of profitability, ACIU's ROE is -1.02%, compared to REGN's ROE of +0.15%. Regarding short-term risk, ACIU is more volatile compared to REGN. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check REGN's competition here
ACIU vs VRNA Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, VRNA has a market cap of 72.7B. Regarding current trading prices, ACIU is priced at $3.07, while VRNA trades at $106.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas VRNA's P/E ratio is -102.80. In terms of profitability, ACIU's ROE is -1.02%, compared to VRNA's ROE of -0.13%. Regarding short-term risk, ACIU is more volatile compared to VRNA. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check VRNA's competition here
ACIU vs ARGX Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, ARGX has a market cap of 51.3B. Regarding current trading prices, ACIU is priced at $3.07, while ARGX trades at $828.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas ARGX's P/E ratio is 42.26. In terms of profitability, ACIU's ROE is -1.02%, compared to ARGX's ROE of +0.34%. Regarding short-term risk, ACIU is more volatile compared to ARGX. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check ARGX's competition here
ACIU vs SGEN Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, SGEN has a market cap of 43.2B. Regarding current trading prices, ACIU is priced at $3.07, while SGEN trades at $228.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas SGEN's P/E ratio is -57.19. In terms of profitability, ACIU's ROE is -1.02%, compared to SGEN's ROE of -0.21%. Regarding short-term risk, ACIU is more volatile compared to SGEN. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check SGEN's competition here
ACIU vs ALNY Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, ALNY has a market cap of 42.5B. Regarding current trading prices, ACIU is priced at $3.07, while ALNY trades at $320.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas ALNY's P/E ratio is 136.23. In terms of profitability, ACIU's ROE is -1.02%, compared to ALNY's ROE of +0.90%. Regarding short-term risk, ACIU is more volatile compared to ALNY. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check ALNY's competition here
ACIU vs INSM Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, INSM has a market cap of 30.8B. Regarding current trading prices, ACIU is priced at $3.07, while INSM trades at $142.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas INSM's P/E ratio is -22.21. In terms of profitability, ACIU's ROE is -1.02%, compared to INSM's ROE of -1.68%. Regarding short-term risk, ACIU is more volatile compared to INSM. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check INSM's competition here
ACIU vs RVMD Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, RVMD has a market cap of 29.5B. Regarding current trading prices, ACIU is priced at $3.07, while RVMD trades at $149.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas RVMD's P/E ratio is -25.05. In terms of profitability, ACIU's ROE is -1.02%, compared to RVMD's ROE of -0.63%. Regarding short-term risk, ACIU is more volatile compared to RVMD. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check RVMD's competition here
ACIU vs BNTX Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, BNTX has a market cap of 25.7B. Regarding current trading prices, ACIU is priced at $3.07, while BNTX trades at $102.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas BNTX's P/E ratio is -18.64. In terms of profitability, ACIU's ROE is -1.02%, compared to BNTX's ROE of -0.06%. Regarding short-term risk, ACIU is more volatile compared to BNTX. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check BNTX's competition here
ACIU vs UTHR Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, UTHR has a market cap of 25.4B. Regarding current trading prices, ACIU is priced at $3.07, while UTHR trades at $580.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas UTHR's P/E ratio is 20.85. In terms of profitability, ACIU's ROE is -1.02%, compared to UTHR's ROE of +0.19%. Regarding short-term risk, ACIU is more volatile compared to UTHR. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check UTHR's competition here
ACIU vs MRNA Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, MRNA has a market cap of 21.6B. Regarding current trading prices, ACIU is priced at $3.07, while MRNA trades at $54.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas MRNA's P/E ratio is -7.53. In terms of profitability, ACIU's ROE is -1.02%, compared to MRNA's ROE of -0.30%. Regarding short-term risk, ACIU is more volatile compared to MRNA. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check MRNA's competition here
ACIU vs ROIV Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, ROIV has a market cap of 20.9B. Regarding current trading prices, ACIU is priced at $3.07, while ROIV trades at $29.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas ROIV's P/E ratio is -24.95. In terms of profitability, ACIU's ROE is -1.02%, compared to ROIV's ROE of -0.18%. Regarding short-term risk, ACIU is more volatile compared to ROIV. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check ROIV's competition here
ACIU vs RPRX Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, RPRX has a market cap of 20.8B. Regarding current trading prices, ACIU is priced at $3.07, while RPRX trades at $48.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas RPRX's P/E ratio is 27.23. In terms of profitability, ACIU's ROE is -1.02%, compared to RPRX's ROE of +0.12%. Regarding short-term risk, ACIU is more volatile compared to RPRX. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check RPRX's competition here
ACIU vs BGNE Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, BGNE has a market cap of 20.2B. Regarding current trading prices, ACIU is priced at $3.07, while BGNE trades at $184.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas BGNE's P/E ratio is -22.55. In terms of profitability, ACIU's ROE is -1.02%, compared to BGNE's ROE of +0.07%. Regarding short-term risk, ACIU is more volatile compared to BGNE. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check BGNE's competition here
ACIU vs INCY Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, INCY has a market cap of 19B. Regarding current trading prices, ACIU is priced at $3.07, while INCY trades at $95.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas INCY's P/E ratio is 14.87. In terms of profitability, ACIU's ROE is -1.02%, compared to INCY's ROE of +0.29%. Regarding short-term risk, ACIU is more volatile compared to INCY. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check INCY's competition here
ACIU vs DNA-WT Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, DNA-WT has a market cap of 18.7B. Regarding current trading prices, ACIU is priced at $3.07, while DNA-WT trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas DNA-WT's P/E ratio is N/A. In terms of profitability, ACIU's ROE is -1.02%, compared to DNA-WT's ROE of -0.54%. Regarding short-term risk, ACIU is more volatile compared to DNA-WT. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check DNA-WT's competition here
ACIU vs SMMT Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, SMMT has a market cap of 18.2B. Regarding current trading prices, ACIU is priced at $3.07, while SMMT trades at $24.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas SMMT's P/E ratio is -16.96. In terms of profitability, ACIU's ROE is -1.02%, compared to SMMT's ROE of -2.97%. Regarding short-term risk, ACIU is less volatile compared to SMMT. This indicates potentially lower risk in terms of short-term price fluctuations for ACIU.Check SMMT's competition here
ACIU vs GMAB Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, GMAB has a market cap of 17.5B. Regarding current trading prices, ACIU is priced at $3.07, while GMAB trades at $28.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas GMAB's P/E ratio is 18.38. In terms of profitability, ACIU's ROE is -1.02%, compared to GMAB's ROE of +0.14%. Regarding short-term risk, ACIU is more volatile compared to GMAB. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check GMAB's competition here
ACIU vs BBIO Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, BBIO has a market cap of 15B. Regarding current trading prices, ACIU is priced at $3.07, while BBIO trades at $77.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas BBIO's P/E ratio is -20.51. In terms of profitability, ACIU's ROE is -1.02%, compared to BBIO's ROE of +0.39%. Regarding short-term risk, ACIU is more volatile compared to BBIO. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check BBIO's competition here
ACIU vs ASND Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, ASND has a market cap of 14.9B. Regarding current trading prices, ACIU is priced at $3.07, while ASND trades at $242.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas ASND's P/E ratio is -55.18. In terms of profitability, ACIU's ROE is -1.02%, compared to ASND's ROE of +1.28%. Regarding short-term risk, ACIU is more volatile compared to ASND. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check ASND's competition here
ACIU vs KRTX Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, KRTX has a market cap of 12.6B. Regarding current trading prices, ACIU is priced at $3.07, while KRTX trades at $329.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas KRTX's P/E ratio is -28.09. In terms of profitability, ACIU's ROE is -1.02%, compared to KRTX's ROE of -0.36%. Regarding short-term risk, ACIU is more volatile compared to KRTX. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check KRTX's competition here
ACIU vs IONS Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, IONS has a market cap of 12.4B. Regarding current trading prices, ACIU is priced at $3.07, while IONS trades at $75.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas IONS's P/E ratio is -31.62. In terms of profitability, ACIU's ROE is -1.02%, compared to IONS's ROE of -0.69%. Regarding short-term risk, ACIU is more volatile compared to IONS. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check IONS's competition here
ACIU vs JAZZ Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, JAZZ has a market cap of 12.2B. Regarding current trading prices, ACIU is priced at $3.07, while JAZZ trades at $197.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas JAZZ's P/E ratio is -33.87. In terms of profitability, ACIU's ROE is -1.02%, compared to JAZZ's ROE of -0.09%. Regarding short-term risk, ACIU is more volatile compared to JAZZ. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check JAZZ's competition here
ACIU vs MDGL Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, MDGL has a market cap of 12B. Regarding current trading prices, ACIU is priced at $3.07, while MDGL trades at $524.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas MDGL's P/E ratio is -40.81. In terms of profitability, ACIU's ROE is -1.02%, compared to MDGL's ROE of -0.44%. Regarding short-term risk, ACIU is more volatile compared to MDGL. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check MDGL's competition here
ACIU vs EXEL Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, EXEL has a market cap of 11.9B. Regarding current trading prices, ACIU is priced at $3.07, while EXEL trades at $44.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas EXEL's P/E ratio is 15.96. In terms of profitability, ACIU's ROE is -1.02%, compared to EXEL's ROE of +0.37%. Regarding short-term risk, ACIU is more volatile compared to EXEL. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check EXEL's competition here
ACIU vs RNAM Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, RNAM has a market cap of 11.3B. Regarding current trading prices, ACIU is priced at $3.07, while RNAM trades at $72.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas RNAM's P/E ratio is -17.39. In terms of profitability, ACIU's ROE is -1.02%, compared to RNAM's ROE of -0.45%. Regarding short-term risk, ACIU is more volatile compared to RNAM. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check RNAM's competition here
ACIU vs BMRN Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, BMRN has a market cap of 10.4B. Regarding current trading prices, ACIU is priced at $3.07, while BMRN trades at $54.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas BMRN's P/E ratio is 30.06. In terms of profitability, ACIU's ROE is -1.02%, compared to BMRN's ROE of +0.06%. Regarding short-term risk, ACIU is more volatile compared to BMRN. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check BMRN's competition here
ACIU vs RXDX Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, RXDX has a market cap of 9.6B. Regarding current trading prices, ACIU is priced at $3.07, while RXDX trades at $199.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas RXDX's P/E ratio is -56.47. In terms of profitability, ACIU's ROE is -1.02%, compared to RXDX's ROE of -0.31%. Regarding short-term risk, ACIU is more volatile compared to RXDX. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check RXDX's competition here
ACIU vs ARWR Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, ARWR has a market cap of 9.5B. Regarding current trading prices, ACIU is priced at $3.07, while ARWR trades at $67.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas ARWR's P/E ratio is 42.49. In terms of profitability, ACIU's ROE is -1.02%, compared to ARWR's ROE of +0.36%. Regarding short-term risk, ACIU is more volatile compared to ARWR. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check ARWR's competition here
ACIU vs AXSM Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, AXSM has a market cap of 9.4B. Regarding current trading prices, ACIU is priced at $3.07, while AXSM trades at $184.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas AXSM's P/E ratio is -49.91. In terms of profitability, ACIU's ROE is -1.02%, compared to AXSM's ROE of -2.54%. Regarding short-term risk, ACIU is more volatile compared to AXSM. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check AXSM's competition here
ACIU vs TECH Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, TECH has a market cap of 9B. Regarding current trading prices, ACIU is priced at $3.07, while TECH trades at $57.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas TECH's P/E ratio is 108.23. In terms of profitability, ACIU's ROE is -1.02%, compared to TECH's ROE of +0.04%. Regarding short-term risk, ACIU is more volatile compared to TECH. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check TECH's competition here
ACIU vs PCVX Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, PCVX has a market cap of 9B. Regarding current trading prices, ACIU is priced at $3.07, while PCVX trades at $62.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas PCVX's P/E ratio is -11.05. In terms of profitability, ACIU's ROE is -1.02%, compared to PCVX's ROE of -0.26%. Regarding short-term risk, ACIU is more volatile compared to PCVX. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check PCVX's competition here
ACIU vs IMGN Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, IMGN has a market cap of 8.7B. Regarding current trading prices, ACIU is priced at $3.07, while IMGN trades at $31.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas IMGN's P/E ratio is -111.55. In terms of profitability, ACIU's ROE is -1.02%, compared to IMGN's ROE of -0.93%. Regarding short-term risk, ACIU is more volatile compared to IMGN. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check IMGN's competition here
ACIU vs BPMC Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, BPMC has a market cap of 8.4B. Regarding current trading prices, ACIU is priced at $3.07, while BPMC trades at $129.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas BPMC's P/E ratio is -51.58. In terms of profitability, ACIU's ROE is -1.02%, compared to BPMC's ROE of -0.15%. Regarding short-term risk, ACIU is more volatile compared to BPMC. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check BPMC's competition here
ACIU vs CERE Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, CERE has a market cap of 8.2B. Regarding current trading prices, ACIU is priced at $3.07, while CERE trades at $44.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas CERE's P/E ratio is -16.47. In terms of profitability, ACIU's ROE is -1.02%, compared to CERE's ROE of -0.72%. Regarding short-term risk, ACIU is more volatile compared to CERE. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check CERE's competition here
ACIU vs CYTK Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, CYTK has a market cap of 8.1B. Regarding current trading prices, ACIU is priced at $3.07, while CYTK trades at $65.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas CYTK's P/E ratio is -10.00. In terms of profitability, ACIU's ROE is -1.02%, compared to CYTK's ROE of +1.73%. Regarding short-term risk, ACIU is more volatile compared to CYTK. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check CYTK's competition here
ACIU vs ABVX Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, ABVX has a market cap of 8B. Regarding current trading prices, ACIU is priced at $3.07, while ABVX trades at $122.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas ABVX's P/E ratio is -21.74. In terms of profitability, ACIU's ROE is -1.02%, compared to ABVX's ROE of -1.59%. Regarding short-term risk, ACIU is more volatile compared to ABVX. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check ABVX's competition here
ACIU vs HALO Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, HALO has a market cap of 7.9B. Regarding current trading prices, ACIU is priced at $3.07, while HALO trades at $66.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas HALO's P/E ratio is 26.03. In terms of profitability, ACIU's ROE is -1.02%, compared to HALO's ROE of +0.93%. Regarding short-term risk, ACIU is more volatile compared to HALO. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check HALO's competition here
ACIU vs KRYS Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, KRYS has a market cap of 7.7B. Regarding current trading prices, ACIU is priced at $3.07, while KRYS trades at $264.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas KRYS's P/E ratio is 38.61. In terms of profitability, ACIU's ROE is -1.02%, compared to KRYS's ROE of +0.19%. Regarding short-term risk, ACIU is more volatile compared to KRYS. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check KRYS's competition here
ACIU vs NUVL Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, NUVL has a market cap of 7.6B. Regarding current trading prices, ACIU is priced at $3.07, while NUVL trades at $103.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas NUVL's P/E ratio is -17.75. In terms of profitability, ACIU's ROE is -1.02%, compared to NUVL's ROE of -0.42%. Regarding short-term risk, ACIU is more volatile compared to NUVL. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check NUVL's competition here
ACIU vs IBRX Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, IBRX has a market cap of 7.5B. Regarding current trading prices, ACIU is priced at $3.07, while IBRX trades at $7.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas IBRX's P/E ratio is -19.08. In terms of profitability, ACIU's ROE is -1.02%, compared to IBRX's ROE of +0.64%. Regarding short-term risk, ACIU is less volatile compared to IBRX. This indicates potentially lower risk in terms of short-term price fluctuations for ACIU.Check IBRX's competition here
ACIU vs MTSR Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, MTSR has a market cap of 7.4B. Regarding current trading prices, ACIU is priced at $3.07, while MTSR trades at $70.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas MTSR's P/E ratio is -23.58. In terms of profitability, ACIU's ROE is -1.02%, compared to MTSR's ROE of -0.80%. Regarding short-term risk, ACIU is more volatile compared to MTSR. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check MTSR's competition here
ACIU vs KYMR Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, KYMR has a market cap of 7B. Regarding current trading prices, ACIU is priced at $3.07, while KYMR trades at $86.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas KYMR's P/E ratio is -23.34. In terms of profitability, ACIU's ROE is -1.02%, compared to KYMR's ROE of -0.29%. Regarding short-term risk, ACIU is more volatile compared to KYMR. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check KYMR's competition here
ACIU vs MRUS Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, MRUS has a market cap of 6.8B. Regarding current trading prices, ACIU is priced at $3.07, while MRUS trades at $90.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas MRUS's P/E ratio is -17.05. In terms of profitability, ACIU's ROE is -1.02%, compared to MRUS's ROE of -0.51%. Regarding short-term risk, ACIU is more volatile compared to MRUS. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check MRUS's competition here
ACIU vs PRAX Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, PRAX has a market cap of 6.8B. Regarding current trading prices, ACIU is priced at $3.07, while PRAX trades at $320.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas PRAX's P/E ratio is -23.79. In terms of profitability, ACIU's ROE is -1.02%, compared to PRAX's ROE of -0.59%. Regarding short-term risk, ACIU is more volatile compared to PRAX. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check PRAX's competition here
ACIU vs ACLX Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, ACLX has a market cap of 6.7B. Regarding current trading prices, ACIU is priced at $3.07, while ACLX trades at $115.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas ACLX's P/E ratio is -28.28. In terms of profitability, ACIU's ROE is -1.02%, compared to ACLX's ROE of -0.55%. Regarding short-term risk, ACIU is more volatile compared to ACLX. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check ACLX's competition here
ACIU vs PTGX Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, PTGX has a market cap of 6.6B. Regarding current trading prices, ACIU is priced at $3.07, while PTGX trades at $103.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas PTGX's P/E ratio is -50.60. In terms of profitability, ACIU's ROE is -1.02%, compared to PTGX's ROE of -0.20%. Regarding short-term risk, ACIU is more volatile compared to PTGX. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check PTGX's competition here
ACIU vs RETA Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, RETA has a market cap of 6.6B. Regarding current trading prices, ACIU is priced at $3.07, while RETA trades at $172.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas RETA's P/E ratio is -66.29. In terms of profitability, ACIU's ROE is -1.02%, compared to RETA's ROE of +0.47%. Regarding short-term risk, ACIU is more volatile compared to RETA. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check RETA's competition here
ACIU vs BLTE Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, BLTE has a market cap of 6.3B. Regarding current trading prices, ACIU is priced at $3.07, while BLTE trades at $158.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas BLTE's P/E ratio is -68.42. In terms of profitability, ACIU's ROE is -1.02%, compared to BLTE's ROE of -0.23%. Regarding short-term risk, ACIU is more volatile compared to BLTE. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check BLTE's competition here
ACIU vs CELC Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, CELC has a market cap of 6.1B. Regarding current trading prices, ACIU is priced at $3.07, while CELC trades at $125.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas CELC's P/E ratio is -32.96. In terms of profitability, ACIU's ROE is -1.02%, compared to CELC's ROE of -2.03%. Regarding short-term risk, ACIU is more volatile compared to CELC. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check CELC's competition here
ACIU vs RYTM Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, RYTM has a market cap of 6B. Regarding current trading prices, ACIU is priced at $3.07, while RYTM trades at $88.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas RYTM's P/E ratio is -28.33. In terms of profitability, ACIU's ROE is -1.02%, compared to RYTM's ROE of -1.79%. Regarding short-term risk, ACIU is more volatile compared to RYTM. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check RYTM's competition here
ACIU vs PTCT Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, PTCT has a market cap of 5.9B. Regarding current trading prices, ACIU is priced at $3.07, while PTCT trades at $71.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas PTCT's P/E ratio is 8.36. In terms of profitability, ACIU's ROE is -1.02%, compared to PTCT's ROE of -3.62%. Regarding short-term risk, ACIU is more volatile compared to PTCT. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check PTCT's competition here
ACIU vs CNTA Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, CNTA has a market cap of 5.9B. Regarding current trading prices, ACIU is priced at $3.07, while CNTA trades at $39.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas CNTA's P/E ratio is -27.08. In terms of profitability, ACIU's ROE is -1.02%, compared to CNTA's ROE of -0.51%. Regarding short-term risk, ACIU is more volatile compared to CNTA. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check CNTA's competition here
ACIU vs COGT Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, COGT has a market cap of 5.9B. Regarding current trading prices, ACIU is priced at $3.07, while COGT trades at $36.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas COGT's P/E ratio is -16.75. In terms of profitability, ACIU's ROE is -1.02%, compared to COGT's ROE of -1.00%. Regarding short-term risk, ACIU is more volatile compared to COGT. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check COGT's competition here
ACIU vs CAI Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, CAI has a market cap of 5.8B. Regarding current trading prices, ACIU is priced at $3.07, while CAI trades at $20.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas CAI's P/E ratio is -6.34. In terms of profitability, ACIU's ROE is -1.02%, compared to CAI's ROE of +0.25%. Regarding short-term risk, ACIU is more volatile compared to CAI. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check CAI's competition here
ACIU vs SRRK Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, SRRK has a market cap of 5.7B. Regarding current trading prices, ACIU is priced at $3.07, while SRRK trades at $50.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas SRRK's P/E ratio is -15.20. In terms of profitability, ACIU's ROE is -1.02%, compared to SRRK's ROE of -1.46%. Regarding short-term risk, ACIU is more volatile compared to SRRK. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check SRRK's competition here
ACIU vs ERAS Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, ERAS has a market cap of 5.7B. Regarding current trading prices, ACIU is priced at $3.07, while ERAS trades at $18.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas ERAS's P/E ratio is -41.43. In terms of profitability, ACIU's ROE is -1.02%, compared to ERAS's ROE of -0.34%. Regarding short-term risk, ACIU is more volatile compared to ERAS. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check ERAS's competition here
ACIU vs ALKS Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, ALKS has a market cap of 5.6B. Regarding current trading prices, ACIU is priced at $3.07, while ALKS trades at $33.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas ALKS's P/E ratio is 23.61. In terms of profitability, ACIU's ROE is -1.02%, compared to ALKS's ROE of +0.14%. Regarding short-term risk, ACIU is more volatile compared to ALKS. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check ALKS's competition here
ACIU vs CDTX Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, CDTX has a market cap of 5.6B. Regarding current trading prices, ACIU is priced at $3.07, while CDTX trades at $221.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas CDTX's P/E ratio is -19.77. In terms of profitability, ACIU's ROE is -1.02%, compared to CDTX's ROE of -0.60%. Regarding short-term risk, ACIU is more volatile compared to CDTX. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check CDTX's competition here
ACIU vs CGON Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, CGON has a market cap of 5.6B. Regarding current trading prices, ACIU is priced at $3.07, while CGON trades at $66.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas CGON's P/E ratio is -31.89. In terms of profitability, ACIU's ROE is -1.02%, compared to CGON's ROE of -0.23%. Regarding short-term risk, ACIU is more volatile compared to CGON. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check CGON's competition here
ACIU vs IMVT Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, IMVT has a market cap of 5.6B. Regarding current trading prices, ACIU is priced at $3.07, while IMVT trades at $27.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas IMVT's P/E ratio is -10.24. In terms of profitability, ACIU's ROE is -1.02%, compared to IMVT's ROE of -0.66%. Regarding short-term risk, ACIU is more volatile compared to IMVT. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check IMVT's competition here
ACIU vs ABCM Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, ABCM has a market cap of 5.5B. Regarding current trading prices, ACIU is priced at $3.07, while ABCM trades at $23.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas ABCM's P/E ratio is 2399.00. In terms of profitability, ACIU's ROE is -1.02%, compared to ABCM's ROE of -0.01%. Regarding short-term risk, ACIU is more volatile compared to ABCM. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check ABCM's competition here
ACIU vs ISEE Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, ISEE has a market cap of 5.5B. Regarding current trading prices, ACIU is priced at $3.07, while ISEE trades at $39.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas ISEE's P/E ratio is -22.44. In terms of profitability, ACIU's ROE is -1.02%, compared to ISEE's ROE of -0.39%. Regarding short-term risk, ACIU is more volatile compared to ISEE. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check ISEE's competition here
ACIU vs TGTX Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, TGTX has a market cap of 5.5B. Regarding current trading prices, ACIU is priced at $3.07, while TGTX trades at $34.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas TGTX's P/E ratio is 12.38. In terms of profitability, ACIU's ROE is -1.02%, compared to TGTX's ROE of +1.01%. Regarding short-term risk, ACIU is more volatile compared to TGTX. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check TGTX's competition here
ACIU vs FBIOX Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, FBIOX has a market cap of 5.4B. Regarding current trading prices, ACIU is priced at $3.07, while FBIOX trades at $25.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas FBIOX's P/E ratio is N/A. In terms of profitability, ACIU's ROE is -1.02%, compared to FBIOX's ROE of +0.00%. Regarding short-term risk, ACIU is more volatile compared to FBIOX. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check FBIOX's competition here
ACIU vs CRSP Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, CRSP has a market cap of 5.3B. Regarding current trading prices, ACIU is priced at $3.07, while CRSP trades at $55.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas CRSP's P/E ratio is -8.61. In terms of profitability, ACIU's ROE is -1.02%, compared to CRSP's ROE of -0.32%. Regarding short-term risk, ACIU is more volatile compared to CRSP. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check CRSP's competition here
ACIU vs APLS Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, APLS has a market cap of 5.2B. Regarding current trading prices, ACIU is priced at $3.07, while APLS trades at $40.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas APLS's P/E ratio is 227.06. In terms of profitability, ACIU's ROE is -1.02%, compared to APLS's ROE of +0.08%. Regarding short-term risk, ACIU is more volatile compared to APLS. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check APLS's competition here
ACIU vs APGE Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, APGE has a market cap of 5.1B. Regarding current trading prices, ACIU is priced at $3.07, while APGE trades at $90.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas APGE's P/E ratio is -21.46. In terms of profitability, ACIU's ROE is -1.02%, compared to APGE's ROE of -0.37%. Regarding short-term risk, ACIU is more volatile compared to APGE. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check APGE's competition here
ACIU vs MIRM Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, MIRM has a market cap of 4.8B. Regarding current trading prices, ACIU is priced at $3.07, while MIRM trades at $95.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas MIRM's P/E ratio is -203.96. In terms of profitability, ACIU's ROE is -1.02%, compared to MIRM's ROE of -0.09%. Regarding short-term risk, ACIU is more volatile compared to MIRM. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check MIRM's competition here
ACIU vs TERN Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, TERN has a market cap of 4.7B. Regarding current trading prices, ACIU is priced at $3.07, while TERN trades at $52.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas TERN's P/E ratio is -51.16. In terms of profitability, ACIU's ROE is -1.02%, compared to TERN's ROE of -0.20%. Regarding short-term risk, ACIU is more volatile compared to TERN. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check TERN's competition here
ACIU vs CORT Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, CORT has a market cap of 4.7B. Regarding current trading prices, ACIU is priced at $3.07, while CORT trades at $43.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas CORT's P/E ratio is 53.61. In terms of profitability, ACIU's ROE is -1.02%, compared to CORT's ROE of +0.15%. Regarding short-term risk, ACIU is more volatile compared to CORT. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check CORT's competition here
ACIU vs XENE Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, XENE has a market cap of 4.6B. Regarding current trading prices, ACIU is priced at $3.07, while XENE trades at $58.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas XENE's P/E ratio is -13.40. In terms of profitability, ACIU's ROE is -1.02%, compared to XENE's ROE of -0.56%. Regarding short-term risk, ACIU is more volatile compared to XENE. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check XENE's competition here
ACIU vs FOLD Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, FOLD has a market cap of 4.5B. Regarding current trading prices, ACIU is priced at $3.07, while FOLD trades at $14.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas FOLD's P/E ratio is -160.56. In terms of profitability, ACIU's ROE is -1.02%, compared to FOLD's ROE of -0.12%. Regarding short-term risk, ACIU is more volatile compared to FOLD. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check FOLD's competition here
ACIU vs AKRO Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, AKRO has a market cap of 4.5B. Regarding current trading prices, ACIU is priced at $3.07, while AKRO trades at $54.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas AKRO's P/E ratio is -14.57. In terms of profitability, ACIU's ROE is -1.02%, compared to AKRO's ROE of -0.31%. Regarding short-term risk, ACIU is more volatile compared to AKRO. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check AKRO's competition here
ACIU vs ALPN Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, ALPN has a market cap of 4.5B. Regarding current trading prices, ACIU is priced at $3.07, while ALPN trades at $64.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas ALPN's P/E ratio is -101.52. In terms of profitability, ACIU's ROE is -1.02%, compared to ALPN's ROE of -0.13%. Regarding short-term risk, ACIU is more volatile compared to ALPN. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check ALPN's competition here
ACIU vs LGND Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, LGND has a market cap of 4.5B. Regarding current trading prices, ACIU is priced at $3.07, while LGND trades at $223.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas LGND's P/E ratio is 36.42. In terms of profitability, ACIU's ROE is -1.02%, compared to LGND's ROE of +0.14%. Regarding short-term risk, ACIU is more volatile compared to LGND. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check LGND's competition here
ACIU vs OPT Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, OPT has a market cap of 4.2B. Regarding current trading prices, ACIU is priced at $3.07, while OPT trades at $3.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas OPT's P/E ratio is -1.52. In terms of profitability, ACIU's ROE is -1.02%, compared to OPT's ROE of +0.88%. Regarding short-term risk, ACIU is more volatile compared to OPT. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check OPT's competition here
ACIU vs SYRE Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, SYRE has a market cap of 4.2B. Regarding current trading prices, ACIU is priced at $3.07, while SYRE trades at $69.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas SYRE's P/E ratio is -35.20. In terms of profitability, ACIU's ROE is -1.02%, compared to SYRE's ROE of -0.29%. Regarding short-term risk, ACIU is more volatile compared to SYRE. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check SYRE's competition here
ACIU vs MRTX Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, MRTX has a market cap of 4.1B. Regarding current trading prices, ACIU is priced at $3.07, while MRTX trades at $58.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas MRTX's P/E ratio is -4.82. In terms of profitability, ACIU's ROE is -1.02%, compared to MRTX's ROE of -0.62%. Regarding short-term risk, ACIU is more volatile compared to MRTX. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check MRTX's competition here
ACIU vs VKTX Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, VKTX has a market cap of 4.1B. Regarding current trading prices, ACIU is priced at $3.07, while VKTX trades at $35.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas VKTX's P/E ratio is -11.13. In terms of profitability, ACIU's ROE is -1.02%, compared to VKTX's ROE of -0.48%. Regarding short-term risk, ACIU is more volatile compared to VKTX. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check VKTX's competition here
ACIU vs CRNX Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, CRNX has a market cap of 4.1B. Regarding current trading prices, ACIU is priced at $3.07, while CRNX trades at $39.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas CRNX's P/E ratio is -7.88. In terms of profitability, ACIU's ROE is -1.02%, compared to CRNX's ROE of -0.41%. Regarding short-term risk, ACIU is more volatile compared to CRNX. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check CRNX's competition here
ACIU vs LEGN Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, LEGN has a market cap of 3.9B. Regarding current trading prices, ACIU is priced at $3.07, while LEGN trades at $21.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas LEGN's P/E ratio is -13.01. In terms of profitability, ACIU's ROE is -1.02%, compared to LEGN's ROE of -0.29%. Regarding short-term risk, ACIU is more volatile compared to LEGN. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check LEGN's competition here
ACIU vs NAMS Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, NAMS has a market cap of 3.8B. Regarding current trading prices, ACIU is priced at $3.07, while NAMS trades at $33.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas NAMS's P/E ratio is -19.30. In terms of profitability, ACIU's ROE is -1.02%, compared to NAMS's ROE of -0.27%. Regarding short-term risk, ACIU is more volatile compared to NAMS. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check NAMS's competition here
ACIU vs RYZB Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, RYZB has a market cap of 3.8B. Regarding current trading prices, ACIU is priced at $3.07, while RYZB trades at $62.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas RYZB's P/E ratio is -57.86. In terms of profitability, ACIU's ROE is -1.02%, compared to RYZB's ROE of +0.83%. Regarding short-term risk, ACIU is more volatile compared to RYZB. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check RYZB's competition here
ACIU vs CBAY Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, CBAY has a market cap of 3.7B. Regarding current trading prices, ACIU is priced at $3.07, while CBAY trades at $32.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas CBAY's P/E ratio is -32.81. In terms of profitability, ACIU's ROE is -1.02%, compared to CBAY's ROE of -0.64%. Regarding short-term risk, ACIU is more volatile compared to CBAY. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check CBAY's competition here
ACIU vs LQDA Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, LQDA has a market cap of 3.6B. Regarding current trading prices, ACIU is priced at $3.07, while LQDA trades at $41.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas LQDA's P/E ratio is -51.75. In terms of profitability, ACIU's ROE is -1.02%, compared to LQDA's ROE of -2.09%. Regarding short-term risk, ACIU is more volatile compared to LQDA. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check LQDA's competition here
ACIU vs TVTX Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, TVTX has a market cap of 3.6B. Regarding current trading prices, ACIU is priced at $3.07, while TVTX trades at $39.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas TVTX's P/E ratio is -69.37. In terms of profitability, ACIU's ROE is -1.02%, compared to TVTX's ROE of -0.79%. Regarding short-term risk, ACIU is more volatile compared to TVTX. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check TVTX's competition here
ACIU vs TLX Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, TLX has a market cap of 3.6B. Regarding current trading prices, ACIU is priced at $3.07, while TLX trades at $10.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas TLX's P/E ratio is -537.00. In terms of profitability, ACIU's ROE is -1.02%, compared to TLX's ROE of -0.02%. Regarding short-term risk, ACIU is more volatile compared to TLX. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check TLX's competition here
ACIU vs ACAD Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, ACAD has a market cap of 3.6B. Regarding current trading prices, ACIU is priced at $3.07, while ACAD trades at $21.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas ACAD's P/E ratio is 9.24. In terms of profitability, ACIU's ROE is -1.02%, compared to ACAD's ROE of +0.42%. Regarding short-term risk, ACIU is more volatile compared to ACAD. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check ACAD's competition here
ACIU vs DNTH Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, DNTH has a market cap of 3.6B. Regarding current trading prices, ACIU is priced at $3.07, while DNTH trades at $92.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas DNTH's P/E ratio is -22.12. In terms of profitability, ACIU's ROE is -1.02%, compared to DNTH's ROE of +0.00%. Regarding short-term risk, ACIU is more volatile compared to DNTH. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check DNTH's competition here
ACIU vs EWTX Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, EWTX has a market cap of 3.6B. Regarding current trading prices, ACIU is priced at $3.07, while EWTX trades at $33.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas EWTX's P/E ratio is -20.32. In terms of profitability, ACIU's ROE is -1.02%, compared to EWTX's ROE of -0.32%. Regarding short-term risk, ACIU is more volatile compared to EWTX. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check EWTX's competition here
ACIU vs SWTX Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, SWTX has a market cap of 3.5B. Regarding current trading prices, ACIU is priced at $3.07, while SWTX trades at $46.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas SWTX's P/E ratio is -13.78. In terms of profitability, ACIU's ROE is -1.02%, compared to SWTX's ROE of -0.36%. Regarding short-term risk, ACIU is more volatile compared to SWTX. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check SWTX's competition here
ACIU vs KNSA Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, KNSA has a market cap of 3.4B. Regarding current trading prices, ACIU is priced at $3.07, while KNSA trades at $45.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas KNSA's P/E ratio is 60.43. In terms of profitability, ACIU's ROE is -1.02%, compared to KNSA's ROE of +0.11%. Regarding short-term risk, ACIU is more volatile compared to KNSA. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check KNSA's competition here
ACIU vs DYN Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, DYN has a market cap of 3.3B. Regarding current trading prices, ACIU is priced at $3.07, while DYN trades at $19.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas DYN's P/E ratio is -5.74. In terms of profitability, ACIU's ROE is -1.02%, compared to DYN's ROE of -0.61%. Regarding short-term risk, ACIU is more volatile compared to DYN. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check DYN's competition here
ACIU vs DNLI Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, DNLI has a market cap of 3.3B. Regarding current trading prices, ACIU is priced at $3.07, while DNLI trades at $20.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas DNLI's P/E ratio is -6.97. In terms of profitability, ACIU's ROE is -1.02%, compared to DNLI's ROE of -0.50%. Regarding short-term risk, ACIU is more volatile compared to DNLI. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check DNLI's competition here
ACIU vs CPRX Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, CPRX has a market cap of 3.2B. Regarding current trading prices, ACIU is priced at $3.07, while CPRX trades at $25.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas CPRX's P/E ratio is 15.41. In terms of profitability, ACIU's ROE is -1.02%, compared to CPRX's ROE of +0.24%. Regarding short-term risk, ACIU is more volatile compared to CPRX. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check CPRX's competition here
ACIU vs BEAM Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, BEAM has a market cap of 3.1B. Regarding current trading prices, ACIU is priced at $3.07, while BEAM trades at $30.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas BEAM's P/E ratio is -37.44. In terms of profitability, ACIU's ROE is -1.02%, compared to BEAM's ROE of -0.07%. Regarding short-term risk, ACIU is more volatile compared to BEAM. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check BEAM's competition here
ACIU vs GPCR Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, GPCR has a market cap of 3.1B. Regarding current trading prices, ACIU is priced at $3.07, while GPCR trades at $53.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas GPCR's P/E ratio is -22.29. In terms of profitability, ACIU's ROE is -1.02%, compared to GPCR's ROE of -0.15%. Regarding short-term risk, ACIU is more volatile compared to GPCR. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check GPCR's competition here
ACIU vs ALMS Comparison April 2026
ACIU plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACIU stands at 312.4M. In comparison, ALMS has a market cap of 3.1B. Regarding current trading prices, ACIU is priced at $3.07, while ALMS trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACIU currently has a P/E ratio of -3.49, whereas ALMS's P/E ratio is -8.74. In terms of profitability, ACIU's ROE is -1.02%, compared to ALMS's ROE of -0.73%. Regarding short-term risk, ACIU is more volatile compared to ALMS. This indicates potentially higher risk in terms of short-term price fluctuations for ACIU.Check ALMS's competition here